News from oramed pharmaceuticals inc A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

( RICS:ORMP)

Feb 04, 2016, 08:15 ET

Oramed to Present at the BIO CEO & Investor Conference

Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) (http://www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral...

Jan 06, 2016, 08:15 ET

Oramed Pharmaceuticals' Shareholder Letter

Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) (http://www.oramed.com), today issued the following shareholder letter: Dear Shareholders,  2015...

Dec 29, 2015, 08:15 ET

Oramed Announces Closing of Licensing and Investment Deal with HTIT for Oral Insulin Capsule in China

Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) (http://www.oramed.com), a developer of oral drug delivery systems, today announced the closing of its...

Nov 30, 2015, 08:16 ET
From left to right: Prof. Avram Hershko, Oramed Scientific Advisory Board; Mr. Nadav Kidron, Oramed CEO; Mr. Bin Zhou, Sinopharm Vice General President; Mr. Xiaoming  Gao, HTIT Chairman [photo: Maoz Vaystooch.  editorial use only/courtesy Oramed.]

Oramed Signs up to $50 Million Licensing and Investment Agreements for Oral Insulin Capsule in China

Oramed Pharmaceuticals Inc. (NASDAQ: ORMP), a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems,...

Oct 01, 2015, 08:15 ET

Oramed to Present at the Aegis Capital Growth Conference

Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) (http://www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral...

Sep 24, 2015, 08:15 ET

Oramed Patent Allowed in the US for Oral Administration of Proteins

Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) (http://www.oramed.com), a developer of oral drug delivery systems, announced today that the Company's...

Sep 09, 2015, 08:15 ET

Oramed Completes Randomization of Over 50% of Patients in Phase IIb Oral Insulin Study

Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) (http://www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral...

Sep 04, 2015, 08:15 ET

Oramed to Present at the Rodman & Renshaw Global Investment Conference

Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) (http://www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral...

Jul 07, 2015, 08:00 ET

Sinopharm Capital-Hefei Signs Letter of Intent with Oramed for $50,000,000 Investment and Licensing Deal in China

Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) (http://www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral...

Jun 30, 2015, 09:18 ET

Oramed Enrolls First Patient in its Phase IIb Oral Insulin Study

Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) (http://www.oramed.com), a clinical-stage pharmaceutical Company focused on the development of oral...

Jun 16, 2015, 08:15 ET

Oramed Granted Patent in Russia for Oral Administration of GLP-1

Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) (http://www.oramed.com), a developer of oral drug delivery systems, announced today that the Russian...

Jun 11, 2015, 08:15 ET

Oramed Announces Closing of $5.36 Million Registered Direct Offering

Oramed Pharmaceuticals Inc. (NASDAQ: ORMP), a developer of oral drug delivery systems, today announced the closing of its previously-announced...

Jun 05, 2015, 08:25 ET

Oramed to Raise $5.36 Million in Registered Direct Offering

Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) (http://www.oramed.com), a developer of oral drug delivery systems, today announced that it entered...

Jun 02, 2015, 08:15 ET

Oramed to Present at the American Diabetes Association 75th Scientific Sessions

Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) (http://www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral...

May 26, 2015, 08:15 ET

Oramed Submits Protocol to U.S. FDA for Its Phase IIb Oral Insulin Study

Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) (http://www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral...

May 05, 2015, 09:25 ET

Oramed to Present at Upcoming Conferences

Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) (http://www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral...

Apr 28, 2015, 09:25 ET

Oramed Pharmaceuticals Inc. Issues Phase IIb Study Update Letter

Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) (http://www.oramed.com) Dear Friends, Shareholders and Associates, I am very excited to announce that...

Apr 20, 2015, 08:15 ET

Oramed to Present at the GTC Diabetes Summit

Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) (http://www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral...

Apr 01, 2015, 10:06 ET

Oramed Enrolls First Patient in its Glucose Clamp Study for Oral Insulin

Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) (http://www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral...

Mar 04, 2015, 08:15 ET

Oramed to Present at the ROTH Conference

Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) (http://www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral...